Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Alteration in Body Composition and Metabolic Profile During Ramadan Fasting in Healthy Men

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03098381
Recruitment Status : Completed
First Posted : March 31, 2017
Last Update Posted : March 31, 2017
Sponsor:
Information provided by (Responsible Party):
Suwimol Sapwarobol, Chulalongkorn University

Brief Summary:
One of religious duties for all healthy adult Muslims is fasting during Ramadan, the ninth month of Islamic lunar calendar. In this month, Ramadan observance fasted (no food and drink) from dawn to dusk. Studies demonstrated daytime fasting may pose a positive significant effect on metabolic health. Thus, this present study aimed to determine the effect of Ramadan fasting on body composition, metabolic profile, serum leptin and adiponectin levels in healthy men.

Condition or disease
Fasting

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 27 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Alteration in Body Composition and Metabolic Profile Without Changes on Serum Leptin and Adiponectin Levels During Ramadan Fasting in Healthy Men
Actual Study Start Date : June 2016
Actual Primary Completion Date : September 2016
Actual Study Completion Date : March 2017



Primary Outcome Measures :
  1. body composition [ Time Frame: 1 months ]
    fat mass changes after 1 month of ramadan fasting in 27 participants


Secondary Outcome Measures :
  1. Metabolic profile [ Time Frame: 1 month ]
    cholesterol change after 1 month of ramadan fasting in 27 participants

  2. Serum leptin and adiponectin measurements [ Time Frame: 1 month ]
    concentrations of Leptin and Adiponectin changes after 1 month of ramadan fasting in 27 participants



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Sampling Method:   Probability Sample
Study Population
27 healthy men (19-31 years) Muslim
Criteria

Inclusion Criteria:

  • age 19-40 years
  • Muslim men
  • fasted completely during Ramadan
  • no known of any metabolic-related diseases.

Exclusion Criteria:

  • any diseases
  • intake of any medication and dietary supplement
  • smoking
  • alcohol drinking

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03098381


Sponsors and Collaborators
Chulalongkorn University
Investigators
Layout table for investigator information
Principal Investigator: Suwimol sapwarobol Chulalongkorn University
Additional Information:
Publications:
Layout table for additonal information
Responsible Party: Suwimol Sapwarobol, Program Director, Nutrition and Dietetics Program, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT03098381    
Other Study ID Numbers: Nutrition and Dietetics Dept
First Posted: March 31, 2017    Key Record Dates
Last Update Posted: March 31, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No